Literature DB >> 10486083

The effect of early inhaled budesonide on pulmonary inflammation in infants with respiratory distress syndrome.

D P Inwald1, K Trivedi, S H Murch, K Costeloe.   

Abstract

UNLABELLED: The aim of this pilot study was to determine the effect of early inhaled budesonide on clinical and inflammatory parameters in preterm infants ventilated for respiratory distress syndrome.
CONCLUSION: Neither the inflammatory process associated with respiratory distress syndrome nor the progression to bronchopulmonary dysplasia appeared to be altered by treatment with inhaled budesonide.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10486083     DOI： 10.1007/s004310051212

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  3 in total

Review 1.  Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

Authors:  Wes Onland; Martin Offringa; Anton van Kaam
Journal:  Cochrane Database Syst Rev       Date:  2017-08-24

2.  Inhaled Budesonide in Neonatal Respiratory Distress Syndrome of Near-Term Neonates: A Randomized, Placebo-Controlled Trial.

Authors:  Mohamed S Elfarargy; Ghada M Al-Ashmawy; Sally M Abu-Risha; Haidy A Khattab
Journal:  J Pediatr Pharmacol Ther       Date:  2021-12-22

3.  Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease.

Authors:  K A Jangaard; D A Stinson; A C Allen; M J Vincer
Journal:  Paediatr Child Health       Date:  2002-01       Impact factor: 2.253
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.